230 related articles for article (PubMed ID: 14724826)
1. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives.
Elmberg M; Hultcrantz R; Ekbom A; Brandt L; Olsson S; Olsson R; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Askling J
Gastroenterology; 2003 Dec; 125(6):1733-41. PubMed ID: 14724826
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
3. Hereditary hemochromatosis and cancer risk: more fuel to the fire?
Mallory MA; Kowdley KV
Gastroenterology; 2001 Nov; 121(5):1253-4. PubMed ID: 11677223
[No Abstract] [Full Text] [Related]
4. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.
Fracanzani AL; Conte D; Fraquelli M; Taioli E; Mattioli M; Losco A; Fargion S
Hepatology; 2001 Mar; 33(3):647-51. PubMed ID: 11230745
[TBL] [Abstract][Full Text] [Related]
5. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
[TBL] [Abstract][Full Text] [Related]
6. Hereditary hemochromatosis.
Fix OK; Kowdley KV
Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
[TBL] [Abstract][Full Text] [Related]
7. Hereditary hemochromatosis.
Crownover BK; Covey CJ
Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis.
Beaton MD; Adams PC
Can J Gastroenterol; 2006 Apr; 20(4):257-60. PubMed ID: 16609753
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
10. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention.
Harrison SA; Bacon BR
Med Clin North Am; 2005 Mar; 89(2):391-409. PubMed ID: 15656932
[TBL] [Abstract][Full Text] [Related]
11. Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives.
Elmberg M; Hultcrantz R; Ebrahim F; Olsson S; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Ekbom A; Askling J
Gastroenterology; 2009 Oct; 137(4):1301-9. PubMed ID: 19622361
[TBL] [Abstract][Full Text] [Related]
12. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
13. Iron, hemochromatosis, and hepatocellular carcinoma.
Kowdley KV
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S79-86. PubMed ID: 15508107
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
[TBL] [Abstract][Full Text] [Related]
15. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?
Fracanzani AL; Borzio M; Roncalli M; Derenzini M; Trerè D; Mattioli M; Taioli E; Fiorelli G; Fargion S
Am J Gastroenterol; 2000 Oct; 95(10):2940-5. PubMed ID: 11051372
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark.
Hsing AW; McLaughlin JK; Olsen JH; Mellemkjar L; Wacholder S; Fraumeni JF
Int J Cancer; 1995 Jan; 60(2):160-2. PubMed ID: 7829208
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
[TBL] [Abstract][Full Text] [Related]
20. Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis.
Bardou-Jacquet E; Morcet J; Manet G; Lainé F; Perrin M; Jouanolle AM; Guyader D; Moirand R; Viel JF; Deugnier Y
J Hepatol; 2015 Mar; 62(3):682-9. PubMed ID: 25450707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
